These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8028071)

  • 21. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
    J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epstein-Barr virus].
    Mendoza Montero J
    Enferm Infecc Microbiol Clin; 1990; 8(7):397-401. PubMed ID: 1967099
    [No Abstract]   [Full Text] [Related]  

  • 23. Epstein-Barr virus in nasopharyngeal carcinoma in Indian patients.
    Rathaur RG; Chitale AR; Banerjee K
    Indian J Cancer; 1999; 36(2-4):80-90. PubMed ID: 10921211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
    Hao SP; Tsang NM; Chang KP
    Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques.
    Gulley ML; Raab-Traub N
    Arch Pathol Lab Med; 1993 Nov; 117(11):1115-20. PubMed ID: 8239932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of Epstein-Barr virus gene in nasopharyngeal carcinoma with neck lymphatic metastasis].
    Li J; Li Q; Li R
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):377-9. PubMed ID: 12759983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
    Ng MH; Chan KH; Ng SP; Zong YS
    Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
    Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
    J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
    Niemhom S; Maeda S; Raksakait K; Petchclai B
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
    Lin JC; Wang WY; Liang WM; Chou HY; Jan JS; Jiang RS; Wang JY; Twu CW; Liang KL; Chao J; Shen WC
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1342-8. PubMed ID: 17449194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma.
    Chua HH; Yeh TH; Wang YP; Sheen TS; Shew JY; Huang YT; Tsai CH
    Head Neck; 2008 Dec; 30(12):1575-85. PubMed ID: 18798303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma.
    Ambinder RF; Robertson KD; Moore SM; Yang J
    Semin Cancer Biol; 1996 Aug; 7(4):217-26. PubMed ID: 8946606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase assay and nested polymerase chain reaction from nasopharyngeal swabs for early noninvasive detection of nasopharyngeal carcinoma.
    Kerekhanjanarong V; Sitawarin S; Sakdikul S; Saengpanich S; Chindavijak S; Supiyaphun P; Voravud N; Mutirangura A
    Otolaryngol Head Neck Surg; 2000 Nov; 123(5):624-9. PubMed ID: 11077353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma.
    Mutirangura A
    Ann N Y Acad Sci; 2001 Sep; 945():59-67. PubMed ID: 11708495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detecting Epstein-Barr virus in nasopharyngeal carcinoma tissue using in situ polymerase chain reaction].
    Xu L; Yang X; Xie L
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):17-8. PubMed ID: 11776587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
    Tan EL; Peh SC; Sam CK
    J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.